Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • News

Intuitive Surgical Q3 Adj. EPS $1.19 Vs Est $1.19

By Benzinga Newsdesk
Today, 5:28 AM
-Bloomberg

ISRG

Read More
3 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook

Earnings Scheduled For October 19, 2021

By Benzinga Insights
Today, 5:28 AM
  Companies Reporting Before The Bell • Signature Bank (NASDAQ:SBNY) is likely to report quarterly earnings at $3.72 per share on revenue of $513.37 million.

AMOV

Read More
2 minute read
  • Earnings
  • Intraday Update
  • Markets
  • News

Price To Earnings Ratio Insights For Intuitive Surgical

By Benzinga Insights
Today, 5:28 AM
 

ISRG

Read More
1 minute read
  • Analyst Ratings

CORRECTION: Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Adjusts Price Target to $310

By Benzinga Newsdesk
Today, 5:28 AM
CORRECTION: Morgan Stanley maintains Intuitive Surgical (NASDAQ:ISRG) with a Equal-Weight and adjusts the price target from $323.5 to $310.

ISRG

Read More
1 minute read
  • General
  • Health Care
  • Movers
  • News
  • Stock Split
  • Trading Ideas

Intuitive Surgical 3-For-1 Stock Split Goes Into Effect

By Vandana Singh
Today, 5:28 AM
Intuitive Surgical Inc (NASDAQ:ISRG) approved a three-for-one split back in August, and it has gone into effect now.  The implementation…

ISRG

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Lowers Price Target to $310

By Benzinga Newsdesk
Today, 5:28 AM
Morgan Stanley maintains Intuitive Surgical (NASDAQ:ISRG) with a Equal-Weight and lowers the price target from $930 to $310.

ISRG

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Citigroup Downgrades Intuitive Surgical to Neutral, Announces $1100 Price Target

By Benzinga Newsdesk
Today, 5:28 AM
Citigroup analyst Joanne Wuensch downgrades Intuitive Surgical (NASDAQ:ISRG) from Buy to Neutral and announces $1100 price target.

ISRG

Read More
2 minute read
  • Insider Trades
  • News
  • Trading Ideas

Notable Intuitive Surgical Insider Trades $5.88 Million In Company Stock

By Benzinga Insights
Today, 5:28 AM
Myriam Curet, EVP And Chief Medical Officer at Intuitive Surgical (NASDAQ:ISRG), made a large buy and sell of company shares on September 9, according to a new SEC filing.

ISRG

Read More
1 minute read
  • Guidance
  • News

Intuitive Surgical Shares Move Sharply Lower; Co Says Guidance Did Not Contemplate Higher Supply Costs Or Impact Of COVID In U.S.; Says Now Seeing Them Both

By Benzinga Newsdesk
Today, 5:28 AM
-Reuters

ISRG

Read More
6 minute read
  • Biotech
  • Earnings
  • FDA
  • News
  • Penny Stocks
  • Small Cap

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi’s Pemphigus Trial Disappointment, Humanigen’s COVID-19 Drug Denied Emergency Use Authorization

By Shanthi Rexaline
Today, 5:28 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)

ABSI

Posts navigation

Previous 1 … 12 13 14 … 20 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service